State IN
Clinical Trials in Indiana
Recruiting clinical trials with at least one study location in Indiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Indiana
NCT05923073 Phase 3
Recruiting
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Acti...
Condition
Crohn's Disease
Enrollment
120 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT07205822 Phase 3
Recruiting
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 ...
Condition
Breast Cancer
Enrollment
100 pts
Location
United States, China, France
Sponsor
AstraZeneca
NCT07006792 Phase 4
Recruiting
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Modera...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
NCT03328611 N/A
Recruiting
MCJR Joint Replacement Clinical Outcomes Database
Condition
Joint Replacement
Enrollment
2,000 pts
Location
United States
Sponsor
Midwest Center for Joint Repla
NCT04160910 Phase 2
Recruiting
5HTP Regulation Of Asthma In Children
Condition
Mild or Moderate Asthma With Allergic Sensitization
Enrollment
20 pts
Location
United States
Sponsor
Indiana University
NCT06856577 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
NCT06193889 Phase 2, Phase 3
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patien...
Condition
Myasthenia Gravis
Enrollment
66 pts
Location
United States, Brazil, Germany
Sponsor
Kyverna Therapeutics
NCT06188702 Phase 1, Phase 2
Recruiting
S095035 as a Single Agent and in Combination in Adult Participants With Advanced...
Condition
MTAP-deleted Solid Tumors
Enrollment
342 pts
Location
United States, Australia, Denmark
Sponsor
Servier Bio-Innovation LLC
NCT03507257 N/A
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Condition
Early Onset Alzheimer Disease
Enrollment
850 pts
Location
United States, Argentina, Netherlands
Sponsor
Indiana University
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT05346796 N/A
Recruiting
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
Condition
Cancer
Enrollment
250 pts
Location
United States
Sponsor
Indiana University
NCT03511118 N/A
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breast...
Condition
Lactating Women on Select DOI
Enrollment
1,600 pts
Location
United States, Canada
Sponsor
Duke University
NCT04711824 Phase 1, Phase 2
Recruiting
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Phys...
Condition
Breast Cancer
Enrollment
41 pts
Location
United States
Sponsor
Colette Shen
NCT07420530 EARLY_Phase 1
Recruiting
Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Mo...
Condition
Exercise-Induced Vocal Cord Dysfunction
Enrollment
120 pts
Location
United States
Sponsor
Indiana University
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
176 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
NCT06345690 N/A
Recruiting
VIA Disc NP Registry 3.0
Condition
Discogenic Pain
Enrollment
500 pts
Location
United States
Sponsor
VIVEX Biologics, Inc.
NCT07096843 Phase 2
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Condition
Primary Membranous Nephropathy
Enrollment
45 pts
Location
United States, Argentina, Brazil
Sponsor
Climb Bio, Inc.
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT06629259 Phase 2
Recruiting
Guanfacine for Alcohol Use Disorder (AUD)
Condition
Alcohol Use Disorder
Enrollment
200 pts
Location
United States
Sponsor
Indiana University
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06827990 N/A
Recruiting
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissection...
Condition
Aortic Dissection
Enrollment
112 pts
Location
United States
Sponsor
W.L.Gore & Associates